Precision Business Insights has published a report on the global theranostics market, estimating its value at USD 2,673 Million in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 16.2% over the forecast period 2025-2031. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.
View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/theranostics-market
The Theranostics Market combines diagnostics and therapeutics into a single method that allows for tailored, focused treatment options. By integrating molecular imaging, biomarker screening, and therapeutic delivery—often via radiopharmaceuticals—theranostics enables doctors to uncover disease-specific features while also administering personalized medicines.
Drivers:
- Rising Cancer Prevalence: High incidence of cancers like prostate, breast, and neuroendocrine tumors driving theranostic applications
- Surge in Precision Medicine Adoption: Increasing demand for personalized therapies based on genetic and molecular profiling
The global theranostics market segmentation:
1) By Product: Diagnostic Imaging, Radiopharmaceuticals, In-vitro diagnostics (IVD)/biomarkers, Screening, and Software and services
2) By Application: Prostate Cancer, Bone Metastasis, Others
3) By End User: Hospitals and Cancer Care Centers, Theranostics Centers, and Research and Academic Centers
Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=814850
Regional Overview:
The report also examines the current concerns and their Future Effects on the theranostics market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the theranostics market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.
- North America (U.S., Canada)
- Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
- Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
- Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)
The competitive landscape is dominated by major players like Curasight, BAMF Health, Cardinal Health Inc., Nuview Life Sciences, Siemens Healthcare AG, Radiopharm Theranostics Ltd., Clarity Pharmaceuticals Ltd., Point Biopharma Global Inc., GE Healthcare Technologies, Canon Medical Systems Corporation
About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.
Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747
